[PDF] Top 20 Linking the structure of alpha synuclein oligmers to function in Parkinson's disease

... epitopes of the three main structural domains of a-syn were utilised for immunodetection. Dot blotting procedures have become a standard method to determine availability of antigenic epitopes on the surface of amyloid ... See full document

... Recent advances in our understanding of how αS confers its cytotoxic effects in susceptible neurons will invariably direct future avenues of study to the prevention and diagnosis of synucleinopathies. The focus in the ... See full document

... of alpha synuclein (α-syn) have emerged as one of the most promising biochemical biomarkers, but its informative value is not sufficient to be used as a diag- nostic tool [14, ...the ... See full document

... of alpha-synuclein in sporadic PD emerged from the asso- ciation between polymorphisms regulating SNCA levels and sporadic PD [14, 15], supporting that alpha- synuclein level is instrumental ... See full document

... studies have found that accumulation, phosphorylation and aggregation of Tau and α -Synuclein are features of distinct neurodegenerative diseases known as Tauopathies and Synucleinopathies, respectively. 1,40 PD ... See full document

... normal function of α-syn is thought to be related to vesicle recycling within the presynaptic terminal involving direct interaction with lipids, whereas, neuronal exosomes are produced via MVB-plasma membrane ... See full document

... PD disease progression [11]. Mitochondrial function and oxidative stress responses related genes have been identified including Parkin, ubiquitin-carboxy-terminal-hydrolase- L1, PINK1, DJ-1 and LRRK2 ... See full document

... Parkinson’s disease pathogenesis remains ...the function of α-synuclein and tau in Parkinson’s disease pathogenesis and raises the possibility that this role that may also be conserved in ... See full document

... fibrillar state. Although Lewy Bodies are still regarded as a clinical hallmark for neurodegenerative diseases, the timing of Lewy Body formation throughout the brain poorly correlates with the onset of symptoms (Terry ... See full document

... As previously mentioned, α-synuclein is the principal component of Lewy Bodies and causes PD when A30P, A53T, or E46K mutations are present. It is a small, 140 amino acid, 14 kDa, natively unfolded protein, but ... See full document

... PD: Parkinson ’ s disease; CHAPS: Care coordination for health promotion and activities in Parkinson ’ s disease; VA: Veterans health administration; CCM: Chronic care model; ... See full document

... Parkinson’s disease is a progressive neurodegenerative disease characterized by loss of nigral dopaminergic neurons associated with rigidity, resting tremor, bradykinesia, and postural ...Parkinson’s ... See full document

... discovery that dopaminergic mid-brain neurons are especially sensitive to oxidative stress inducers such as 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), 6-hydroxydopamine (6-OHDA), rotenone, and paraquat resulted ... See full document

... the disease pathology of Parkinson ’ s disease and ...represent disease end points of the dopaminergic spectrum where Parkinson ’ s disease represents dopamine de fi ... See full document

... infection, falls, confusion, headache, and hallucinations, there was no signi fi cant difference between the two arms. According to the results, we found that pimavanserin may be adequate for use as a fi rst-line treatment ... See full document

... neurodegenerative disease of unknown etiology that is clinically characterized by a variable combination of parkinsonism, cerebellar impairment, and autonomic and motor dysfunction [1, ...with Parkinson ... See full document

... Parkinson’s disease (PD) are now recognized as major contributors to a decreased quality of life [1, ...the disease, and cognitive deficits typically worsen with dis- ease progression ...kinson’s ... See full document

... The intervention of interest is biofeedback. We will include studies that provide swallowing treatment using biofeedback. The biofeedback will involve any external visual, auditory, or tactile cue or combination of cues ... See full document

... Despite the recent development of medical, surgical, and rehabilitative treatments, PD remains a progressive condition; there are no proven management strategies to reverse or halt its pathological processes. Patients ... See full document

... This study is one of the first on HRQoL and caregiver strain in an Australian sample of people caring for fam- ily members with PD. By comparison with the literature, both the caregivers and the care-recipients in our ... See full document